Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

Market Cap	66.28B +2.4%
Revenue (ttm)	327.45B +4.4%
Net Income	6.60B +33.8%
EPS	1.78 +33.6%
Shares Out	n/a
PE Ratio	10.04
Forward PE	14.64
Dividend	0.45 (3.70%)
Ex-Dividend Date	Dec 29, 2025

Volume	4,498,344
Average Volume	3,149,831
Open	12.01
Previous Close	12.15
Day's Range	12.01 - 12.29
52-Week Range	10.82 - 13.12
Beta	0.25
RSI	62.70
Earnings Date	Apr 29, 2026

About HKG:2607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,608
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2607

Financial Performance

In 2025, HKG:2607's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY